<http://webisa.webdatacommons.org/prov/342416053>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://webisa.webdatacommons.org/215024116> .
<http://webisa.webdatacommons.org/prov/61719904>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://webisa.webdatacommons.org/215024116> .
<http://webisa.webdatacommons.org/215024116>	<http://www.w3.org/ns/prov#wasQuotedFrom>	<google.com> .
<http://webisa.webdatacommons.org/215024116>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://www.w3.org/ns/prov#Entity> .
<http://webisa.webdatacommons.org/215024116>	<http://www.w3.org/ns/prov#value>	"Thus, rp molecules (or modulators thereof) of the present invention can be used to treat various body weight disorders, e.g., obesity, cachexia, anorexia, and metabolic disorders such as diabetes." .